178 related articles for article (PubMed ID: 9675142)
1. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.
Glukhov AI; Zimnik OV; Gordeev SA; Severin SE
Biochem Biophys Res Commun; 1998 Jul; 248(2):368-71. PubMed ID: 9675142
[TBL] [Abstract][Full Text] [Related]
2. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
Herbert BS; Pongracz K; Shay JW; Gryaznov SM
Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human telomerase by oligonucleotide chimeras, composed of an antisense moiety and a chemically modified homo-oligonucleotide.
Tarkanyi I; Horváth A; Szatmari I; Eizert H; Vámosi G; Damjanovich S; Ségal-Bendirdjian E; Aradi J
FEBS Lett; 2005 Feb; 579(6):1411-6. PubMed ID: 15733850
[TBL] [Abstract][Full Text] [Related]
4. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human telomerase activity by peptide nucleic acids.
Norton JC; Piatyszek MA; Wright WE; Shay JW; Corey DR
Nat Biotechnol; 1996 May; 14(5):615-9. PubMed ID: 9630953
[TBL] [Abstract][Full Text] [Related]
6. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
Kondo Y; Kondo S
Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820
[TBL] [Abstract][Full Text] [Related]
7. Cellular delivery is a major obstacle for oligodeoxynucleotide inhibition of telomerase activity.
Duncan VE; Ajmani PS; Hughes JA
Anticancer Res; 1998; 18(6A):4105-8. PubMed ID: 9891453
[TBL] [Abstract][Full Text] [Related]
8. Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy.
Ji XM; Xie CH; Fang MH; Zhou FX; Zhang WJ; Zhang MS; Zhou YF
Acta Pharmacol Sin; 2006 Sep; 27(9):1185-91. PubMed ID: 16923339
[TBL] [Abstract][Full Text] [Related]
9. Synergistic down-regulation of telomerase by all-trans retinoic acid and antisense oligonucleotide in oral squamous cell carcinoma cell line (Tca8113).
Zhang P; Xu Q; Chen WT; Duan LQ; Zhang ZY; Zhou XJ
Oral Oncol; 2005 Oct; 41(9):909-15. PubMed ID: 16051514
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
Folini M; Brambilla C; Villa R; Gandellini P; Vignati S; Paduano F; Daidone MG; Zaffaroni N
Eur J Cancer; 2005 Mar; 41(4):624-34. PubMed ID: 15737568
[TBL] [Abstract][Full Text] [Related]
11. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
Lei LX; Chen ZD
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
[TBL] [Abstract][Full Text] [Related]
12. Lipid modification of GRN163, an N3'-->P5' thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition.
Herbert BS; Gellert GC; Hochreiter A; Pongracz K; Wright WE; Zielinska D; Chin AC; Harley CB; Shay JW; Gryaznov SM
Oncogene; 2005 Aug; 24(33):5262-8. PubMed ID: 15940257
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and properties of ENA oligonucleotides targeted to human telomerase RNA subunit.
Horie M; Morita K; Kawakami J; Tsutsumi S; Ando O; Koizumi M
Nucleic Acids Symp Ser (Oxf); 2005; (49):171-2. PubMed ID: 17150688
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.
Fujimoto K; Takahashi M
Biochem Biophys Res Commun; 1997 Dec; 241(3):775-81. PubMed ID: 9434785
[TBL] [Abstract][Full Text] [Related]
15. Telomerase inhibition, oligonucleotides, and clinical trials.
Corey DR
Oncogene; 2002 Jan; 21(4):631-7. PubMed ID: 11850789
[TBL] [Abstract][Full Text] [Related]
16. [Application of antisense human telomerase RNA toward cancer therapy].
Naka K; Yokozaki H; Tahara H; Tahara E
Nihon Rinsho; 1998 May; 56(5):1131-5. PubMed ID: 9613109
[TBL] [Abstract][Full Text] [Related]
17. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells.
Kanazawa Y; Ohkawa K; Ueda K; Mita E; Takehara T; Sasaki Y; Kasahara A; Hayashi N
Biochem Biophys Res Commun; 1996 Aug; 225(2):570-6. PubMed ID: 8753802
[TBL] [Abstract][Full Text] [Related]
18. Oligonucleotide n3'-->p5' phosphoramidates and thio-phoshoramidates as potential therapeutic agents.
Gryaznov SM
Chem Biodivers; 2010 Mar; 7(3):477-93. PubMed ID: 20232321
[TBL] [Abstract][Full Text] [Related]
19. [Antisense oligonucleotides with antitumor activity].
Otvös L; Sági G
Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
[TBL] [Abstract][Full Text] [Related]
20. Rapid blockade of telomerase activity and tumor cell growth by the DPL lipofection of ribbon antisense to hTR.
Bajpai AK; Park JH; Moon IJ; Kang H; Lee YH; Doh KO; Suh SI; Chang BC; Park JG
Oncogene; 2005 Sep; 24(43):6492-501. PubMed ID: 16170384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]